Johnson & Johnson “delay the deployment” of its vaccine in Europe after the “pause” in the United States



Johnson’s Siege – AFP

Johnson & Johnson “delay the deployment” of its vaccine in Europe after the “pause” in the United States. The American health authorities recommended this Tuesday “a pause” in the use of the vaccine against the Covid-19 of Johnson & Johnson, in order to investigate the appearance of serious cases of blood clots in several people in the United States.

The US Medicines Agency (FDA) “is investigating six reported cases in the United States of people who developed rare and severe cases of blood clots after receiving the vaccine,” she said in a statement.



237

shares



Source link